1. Home
  2. SILO vs IMTE Comparison

SILO vs IMTE Comparison

Compare SILO & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • IMTE
  • Stock Information
  • Founded
  • SILO 2010
  • IMTE 2008
  • Country
  • SILO United States
  • IMTE Malaysia
  • Employees
  • SILO N/A
  • IMTE N/A
  • Industry
  • SILO Apparel
  • IMTE Consumer Electronics/Appliances
  • Sector
  • SILO Consumer Discretionary
  • IMTE Consumer Staples
  • Exchange
  • SILO Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • SILO 4.3M
  • IMTE 4.1M
  • IPO Year
  • SILO N/A
  • IMTE N/A
  • Fundamental
  • Price
  • SILO $0.64
  • IMTE $0.99
  • Analyst Decision
  • SILO
  • IMTE
  • Analyst Count
  • SILO 0
  • IMTE 0
  • Target Price
  • SILO N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • SILO 2.2M
  • IMTE 10.6K
  • Earning Date
  • SILO 08-12-2025
  • IMTE 07-07-2025
  • Dividend Yield
  • SILO N/A
  • IMTE N/A
  • EPS Growth
  • SILO N/A
  • IMTE N/A
  • EPS
  • SILO N/A
  • IMTE N/A
  • Revenue
  • SILO $72,102.00
  • IMTE $123,337.00
  • Revenue This Year
  • SILO $1.86
  • IMTE N/A
  • Revenue Next Year
  • SILO N/A
  • IMTE N/A
  • P/E Ratio
  • SILO N/A
  • IMTE N/A
  • Revenue Growth
  • SILO N/A
  • IMTE 4.75
  • 52 Week Low
  • SILO $0.41
  • IMTE $0.51
  • 52 Week High
  • SILO $4.50
  • IMTE $3.17
  • Technical
  • Relative Strength Index (RSI)
  • SILO 51.15
  • IMTE 34.23
  • Support Level
  • SILO $0.60
  • IMTE $0.87
  • Resistance Level
  • SILO $0.61
  • IMTE $1.02
  • Average True Range (ATR)
  • SILO 0.06
  • IMTE 0.05
  • MACD
  • SILO 0.02
  • IMTE -0.01
  • Stochastic Oscillator
  • SILO 43.36
  • IMTE 41.93

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: